CO50 Analysis of Patient-Reported Outcomes of MCO-010 Mutation Agnostic Optogenetic Therapy for Retinitis Pigmento 12-Month Results from a Phase 2b Randomized, Sham-Controlled, Patient- and Assessor-Masked Clinical Trial (RESTORE)
Abstract
Authors
Anish Patel Subrata Batabyal Ramesh Arjunji Samuel Barone Samar Mohanty